Beijing Sun-Novo Pharmaceutical Research Co., Ltd.
Status: Publicly traded
Direct answer
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. is publicly traded on SHH under the ticker 688621.SS.
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. operates as a contract research organization (CRO) in China, primarily focused on the development of chemical and peptide-based pharmaceutical products. Its portfolio includes generic small-molecule chemical drugs and peptide therapies designed to treat a range of conditions such as impetigo, acne, renal anemia, hyperparathyroidism in chronic kidney disease patients...
Can you invest in Beijing Sun-Novo Pharmaceutical Research Co., Ltd.?
Yes. Beijing Sun-Novo Pharmaceutical Research Co., Ltd. is publicly traded on SHH under the ticker 688621.SS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Beijing Sun-Novo Pharmaceutical Research Co., Ltd.
Detailed equity research is provided by MarketSnap.